Skip to content

8-KAccepted Nov 16, 7:30 AM ET

Moleculin Biotech: reports Q3 2026 financial results

MBRXMoleculin Biotech, Inc.

Accepted (ET)

7:30 AM

Nov 16, 2026

Filed

Nov 16, 2026

Documents

15

Size

329.4 KB

Summary

Moleculin Biotech: reports Q3 2026 financial results

Updated

What happened

  • On Nov 16, 2026 Moleculin Biotech issued a press release announcing its financial results for the quarter ended Sep 30, 2026. The filing states the press release is attached as Exhibit 99.1 and is incorporated by reference.

Key details

  • The 8-K reports under Item 2.02: results of operations and financial condition.
  • Press release date: Nov 16, 2026.
  • Reporting period: quarter ended Sep 30, 2026.
  • The press release is included in the filing as Exhibit 99.1.

Why it may matter

  • Item 2.02 covers the company’s reported results of operations and financial condition as disclosed in the attached press release. The filing does not show why the insider traded or why the company acted.

AI-written summary · check the filing